These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7369064)

  • 1. Studies on 20-isopropylidene PGE2 as a new aerosol bronchodilator.
    Murao M; Uchiyama K; Shida A; Sakai K; Yusa T; Yamaguchi T
    Adv Prostaglandin Thromboxane Res; 1980; 7():985-8. PubMed ID: 7369064
    [No Abstract]   [Full Text] [Related]  

  • 2. The bronchodilator activity of 20-isopropylidene prostaglandin E2 (CS-412).
    Yamaguchi T; Sakai K; Yusa T; Yamazaki M
    Prostaglandins; 1980 Sep; 20(3):521-32. PubMed ID: 7422898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of prostaglandin derivatives on a phospholipid basis.
    Lekim D; Sieck A; Betzing H; Kunze H
    Adv Prostaglandin Thromboxane Res; 1978; 3():193-8. PubMed ID: 655006
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of bronchoconstriction by aerosols of prostaglandins E1 and E2.
    Wasserman MA; Griffin RL; Marsalisi FB
    J Pharmacol Exp Ther; 1980 Jul; 214(1):68-73. PubMed ID: 7391972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bronchodilator acitivity of an 11-deoxyprostaglandin (AY 23 578).
    Greenberg R; Smorong K
    Can J Physiol Pharmacol; 1975 Oct; 53(5):799-809. PubMed ID: 1201485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11-Deoxy-11 alpha,12 alpha-methanoprostaglandin E2, a potent, short-acting bronchodilator.
    Davis R; Garay GL; Guzman A; Muchowski JM; Rooks WH; Tomolonis AJ; Velarde E
    J Pharm Sci; 1986 Mar; 75(3):307-12. PubMed ID: 3701618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator activity in vivo and in vitro of four 13,14-didehydro-PGE2 analogues.
    Ceserani R; Marotta F; Usardi MM; Orlando N; Gandolfi C; Bianco S
    Prostaglandins Med; 1979 Jun; 2(6):459-66. PubMed ID: 552097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on carbuterol (SK & F 40383-A), a new selective bronchodilator agent.
    Wardell JR; Colella DF; Shetzline A; Fowler PJ
    J Pharmacol Exp Ther; 1974 Apr; 189(1):167-84. PubMed ID: 4823290
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrointestinal and cardiovascular effects of the prostaglandin analogue Hoe 260.
    Bickel M; Bartmann W; Beck G; Lerch U; Schleyerbach R; Schölkens BA
    Biomed Biochim Acta; 1984; 43(8-9):S235-8. PubMed ID: 6596097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on prostaglandins. VI. Synthesis of 16(S)-methyl-20-methoxy-PGE2 (YPG-209) having oral bronchodilator activity and its analogs.
    Iwamoto H; Inukai N; Yanagisawa I; Ishii Y; Tamura T; Shiozaki T; Takagi T; Tomioka K; Murakami M
    Chem Pharm Bull (Tokyo); 1980 May; 28(5):1422-31. PubMed ID: 7408044
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandins and congeners, 29. (16RS)-(+/-)-15-Deoxy-16-hydroxy-16-vinyl-prostaglandin E2, an orally and transdermally active hypotensive agent of prolonged duration.
    Birnbaum JE; Cervoni P; Chan PS; Chen SM; Floyd MB; Grudzinskas CV; Weiss J; Dessy F
    J Med Chem; 1982 May; 25(5):492-4. PubMed ID: 7086833
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure activity studies leading to a tissue-selective hypotensive prostaglandin analog, 13,14-dihydro-16-phenyl-omega-tetranor PGE2.
    Johnson MR; Schaaf TK; Constantine JW; Hess HJ
    Prostaglandins; 1980 Sep; 20(3):515-20. PubMed ID: 7422897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.
    Tsuboi T; Hatano N; Nakatsuji K; Fujitani B; Yoshida K; Shimizu M; Kawasaki A; Sakata M; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():347-9. PubMed ID: 7386273
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of prostaglandin analogs on the systemic blood circulation].
    Osadchiĭ LI; Khropycheva RP
    Fiziol Zh SSSR Im I M Sechenova; 1983 Jun; 69(6):851-5. PubMed ID: 6683670
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandins V (1). Synthesis and pharmacology of (+/-)-11-deoxy-10-hydroxyprostaglandin E1 methyl ester.
    Caton MP; Darnbrough G; Hambling DJ; Jordon R; Parker T
    Prostaglandins; 1979 Oct; 18(4):569-76. PubMed ID: 531225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator activity of the prostaglandins E 1 and E 2 .
    Rosenthale ME; Dervinis A; Kassarich J
    J Pharmacol Exp Ther; 1971 Sep; 178(3):541-8. PubMed ID: 4328450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. I. Interruption of pregnancy in the first trimester].
    Stoppelli I; Piras G; Dessole S
    Minerva Ginecol; 1983 Dec; 35(12):819-23. PubMed ID: 6243062
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. II. Interruption of pregnancy in the second trimester].
    Stoppelli I; Piras G; Dessole S
    Minerva Ginecol; 1983 Dec; 35(12):825-8. PubMed ID: 6672683
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous erythema and blood pressure lowering effects of topically applied 16-vinylprostaglandins.
    Birnbaum JE; Chan PS; Cervoni P; Dessy F; Van Humbeeck L
    Prostaglandins; 1982 Feb; 23(2):185-99. PubMed ID: 7079519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of sulprostone upon platelet function: in vitro and in vivo studies.
    Briel RC; Lippert TH
    Adv Prostaglandin Thromboxane Res; 1980; 6():351-3. PubMed ID: 7386274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.